<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04775368</url>
  </required_header>
  <id_info>
    <org_study_id>RIPH2_ANDRE_FIBOBS</org_study_id>
    <secondary_id>2020-A02940-39</secondary_id>
    <nct_id>NCT04775368</nct_id>
  </id_info>
  <brief_title>Fibromyalgia Syndrome in France: The Role of Assessment and Management of Sleep Disorders</brief_title>
  <acronym>FIBOBS</acronym>
  <official_title>Syndrome Fibromyalgique en France : Place de l'évaluation et de la Prise en Charge Des Troubles du Sommeil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Emile Roux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Walisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Emile Roux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The FIBOBS study is a multi-center, interventional, prospective study carried out within&#xD;
      specialized chronic pain structures (CPS) in metropolitan France. It will estimate the&#xD;
      prevalence of sleep disorders, divided into three categories (poor quality of sleep in&#xD;
      general, sleep apnea syndrome, restless legs syndrome), using self-questionnaires in patients&#xD;
      with Fibromyalgia Syndrome consulting within a CPS. The interaction between these sleep&#xD;
      disorders and other symptoms of Fibromyalgia Syndrome will also be analyzed using&#xD;
      self-administered questionnaires. Based on the hypothesis that sleep disorders associated&#xD;
      with Fibromyalgia syndrome are only imperfectly assessed and/or treated in CPS, the FIBOBS&#xD;
      study will also interview algologists in order to know both the diagnostic tools used and the&#xD;
      recommended management when sleep disorders are suspected in the context of Fibromyalgia&#xD;
      syndrome. In addition, this study will provide a better understanding of the symptoms of&#xD;
      Fibromyalgia syndrome, their impact and how patients feel.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">January 14, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 14, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessing the prevalence of sleep disorders in general in patients with Fibromyalgia syndrome</measure>
    <time_frame>Only once, by the patient within 14 days of inclusion.</time_frame>
    <description>The prevalence of sleep disorders will be estimated from the results of the Pittsburgh Sleep Quality Index Questionnaire which is a generic, validated 19-item self-administered questionnaire for measuring sleep problems.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessing the prevalence of sleep disorders for the specific risk of sleep apnea syndrome in patients with Fibromyalgia syndrome</measure>
    <time_frame>Only once, by the patient within 14 days of inclusion.</time_frame>
    <description>The prevalence of sleep disorders for the specific risk of sleep apnea syndrome will be estimated from the results of the STOP-BANG questionnaire. This questionnaire guide the diagnosis of sleep apnea syndrome and is composed of 8 items.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessing the prevalence of sleep disorders for the specific risk of restless legs syndrome in patients with Fibromyalgia syndrome</measure>
    <time_frame>Only once, by the patient within 14 days of inclusion.</time_frame>
    <description>The prevalence of sleep disorders will be estimated from the results of the simple question which is a rapid screening tool that provides a diagnosis of probable restless legs syndrome. Patients who answer positively to this question will complete the International Restless Legs Syndrome questionnaire which assesses the severity of restless legs syndrome on four levels: mild, moderate, severe and very severe.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessing the pain severity of Fibromyalgia Syndrome</measure>
    <time_frame>Only once, by the patient within 14 days of inclusion.</time_frame>
    <description>The pain severity of the Fibromyalgia syndrome will be assessed using the WPI (widespread pain index) questionnaire, which represents the generalized pain index.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing the symptom severity of Fibromyalgia Syndrome</measure>
    <time_frame>Only once, by the patient within 14 days of inclusion.</time_frame>
    <description>The symptom severity of the Fibromyalgia syndrome will be assessed using the SSS (symptom severity scale) questionnaire, which corresponds to the symptom severity scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing the feeling of pain and the impact of pain on the patient's daily behavior</measure>
    <time_frame>Only once, by the patient within 14 days of inclusion.</time_frame>
    <description>The painful feeling and the impact of pain on the patient's daily behavior will be assessed by the Concise Pain Questionnaire (QCD), the French version of the Brief Pain Inventory (BPI). This validated questionnaire makes it possible to assess the impact of pain on seven general aspects of the patient's life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the patient's state of anxiety and depression</measure>
    <time_frame>Only once, by the patient within 14 days of inclusion.</time_frame>
    <description>The patient's state of anxiety and depression will be assessed using the validated HADS - Hospital Anxiety and Depression Scale questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the assessment tools used by the algologist to evaluate the main symptoms of Fibromyalgia Syndrome (pain, asthenia, sleep and cognitive disorders)</measure>
    <time_frame>Only once, by the physicien at the inclusion.</time_frame>
    <description>The assessment tools used by the physician algologist to evaluate patients' pain, asthenia, sleep disorders and memory problems will be recorded in the &quot;physician questionnaire&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the therapeutic measures (drug and non-drug) in place for the management of Fibromyalgia Syndrome.</measure>
    <time_frame>Once by the physician at the inclusion, and once by the patient within 14 days of inclusion.</time_frame>
    <description>Therapeutics proposed for the management of symptoms associated with Fibromyalgia Syndrome will be identified (names of drug and non-drug treatments, care practices).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the percentage of patients for whom sleep disorders have been previously diagnosed and treated.</measure>
    <time_frame>Throught study completion, an average of 4 months.</time_frame>
    <description>The &quot;patient questionnaire&quot; will identify patients already diagnosed and treated for a sleep disorder. This will allow comparison with the prevalence calculated from the three screening questionnaires.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">505</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>Diagnosis orientation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For this study, there is only one arm. Each patient complete diagnosis questionnaires.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Administering diagnosis orientation questionnaires for the screening of possible sleep disorders</intervention_name>
    <description>Several diagnosis orientation self-questionnaires will be conducted by the patient following his or her inclusion in order to detect, among other things, possible sleep disorders.</description>
    <arm_group_label>Diagnosis orientation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years old&#xD;
&#xD;
          -  Read, write and understand the French language&#xD;
&#xD;
          -  Patient with a diagnosis of Fibromyalgia Syndrome according to ACR 2010 criteria:&#xD;
             Painful symptoms present at the same intensity for at least 3 months, WPI ≥ 7 and SSS&#xD;
             ≥ 5 OR 3 ≤ WPI ≤ 6 and SSS ≥ 9, Any other cause responsible for chronic osteoarticular&#xD;
             pain must be excluded.Primary or secondary fibromyalgia is eligible, at the discretion&#xD;
             of the investigator.&#xD;
&#xD;
          -  Patient seen in consultation for the first time or for a follow-up visit if the&#xD;
             patient has already been followed up in the specialized chronic pain structure for&#xD;
             less than a year.&#xD;
&#xD;
          -  Have access to an internet connection (for the realization of the &quot;patient&#xD;
             questionnaire&quot;)&#xD;
&#xD;
          -  Patient affiliated to a social security system&#xD;
&#xD;
          -  Written and signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient undergoing anti-cancer treatment or having completed treatment less than 2&#xD;
             years ago&#xD;
&#xD;
          -  Patient under guardianship, deprived of liberty, safeguard of justice&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Patient presenting a serious psychiatric pathology that does not allow compliance with&#xD;
             the completion of the questionnaires (at the discretion of the investigator)&#xD;
&#xD;
          -  Refusal to participate in research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gilbert ANDRE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Emile Roux - Le Puy-en-Velay</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emilie GADEA-DESCHAMPS, PhD</last_name>
    <phone>+33 4 71 04 38 77</phone>
    <email>responsable.rechercheclinique@ch-lepuy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens Picardie - CETD</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Serra</last_name>
      <email>serra.eric@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>Eric Serra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Ardèche Méridionale</name>
      <address>
        <city>Aubenas</city>
        <zip>07200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corine BREYSSE</last_name>
      <email>douleur@ch-ardeche-meridionale.fr</email>
    </contact>
    <investigator>
      <last_name>Ravo TEYSSIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Henri Mondor</name>
      <address>
        <city>Aurillac</city>
        <zip>15000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marlène Vinches</last_name>
      <email>secretariat.douleur@ch-aurillac.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe Sureau</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Jean Minjoz - CETD</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Louis Lajoie</last_name>
      <email>jllajoie@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Louis Lajoie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HIA Clermont Tonnerre</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Pichon</last_name>
      <email>isabelle.pichon@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Marie Binard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital Côte de Nacre - CETD</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amélie Bernard</last_name>
      <email>bernard-am@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Cyril Guillaumé</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Métropole Savoie</name>
      <address>
        <city>Chambéry</city>
        <zip>73011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Journet</last_name>
      <email>douleur.sp@ch-metropole-savoie.fr</email>
    </contact>
    <investigator>
      <last_name>Valérie Roullot-Pradel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Chartres</name>
      <address>
        <city>Chartres</city>
        <zip>28018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie APRELON</last_name>
      <email>saprelon@ch-chartres.fr</email>
    </contact>
    <investigator>
      <last_name>Mouldi HAMROUNI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noémie Delage</last_name>
      <email>ndelage@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Noémie Delage</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Dax</name>
      <address>
        <city>Dax</city>
        <zip>40100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Hélène Boivin</last_name>
      <email>anne-helene.boivin@ght40.fr</email>
    </contact>
    <investigator>
      <last_name>Monique Latare</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Dieppe</name>
      <address>
        <city>Dieppe</city>
        <zip>76200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Defeuillet</last_name>
      <email>cdefeuillet@ch-dieppe.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine Defeuillet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Dreux</name>
      <address>
        <city>Dreux</city>
        <zip>28102</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nelly LEDOUX</last_name>
      <email>nledoux@ch-dreux.fr</email>
    </contact>
    <investigator>
      <last_name>Pedro DE ROA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI Fréjus - Saint Raphaël</name>
      <address>
        <city>Fréjus</city>
        <zip>83608</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hajer Moussa</last_name>
      <email>MOUSSA-H@chi-fsr.fr</email>
    </contact>
    <investigator>
      <last_name>Fadal Maamar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GMH</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Bouheret</last_name>
      <email>paul.bouheret@avec.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Michel Pellat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHD Vendée</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas KACKI</last_name>
      <email>nicolas.kacki@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Yves Marie PLUCHON</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GH Littoral Atlantique</name>
      <address>
        <city>La Rochelle</city>
        <zip>17000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie NOUBLANCHE</last_name>
      <email>Julie.NOUBLANCHE@ght-atlantique17.fr</email>
    </contact>
    <investigator>
      <last_name>Anémone CARVIGAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>CH Emile Roux</name>
      <address>
        <city>Le Puy-en-Velay</city>
        <zip>43000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva GERAUD</last_name>
      <email>eva.geraud@ch-lepuy.fr</email>
    </contact>
    <investigator>
      <last_name>Gilbert ANDRE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Dupuytren 2 - Centre de la douleur chronique</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste de la Porte de Lorient</name>
      <address>
        <city>Lorient</city>
        <zip>56324</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Dherbecourt</last_name>
      <email>olivier.dherbecourt@hospigrandouest.fr</email>
    </contact>
    <investigator>
      <last_name>Lenaig Dy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de la douleur Lille métropole</name>
      <address>
        <city>Marquette-lez-Lille</city>
        <zip>59520</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Hayon Sonsino</last_name>
      <email>hayonsonsino@gmail.com</email>
    </contact>
    <investigator>
      <last_name>David Hayon Sonsino</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Sainte Blandine</name>
      <address>
        <city>Metz</city>
        <zip>57000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny BRUNET</last_name>
      <email>fanny.brunet@hp-metz.fr</email>
    </contact>
    <investigator>
      <last_name>Fanny BRUNET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHi de Mont-de-Marsan</name>
      <address>
        <city>Mont-de-Marsan</city>
        <zip>40024</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Hélène BOIVIN</last_name>
      <email>anne-helene.boivin@ght40.fr</email>
    </contact>
    <investigator>
      <last_name>Paul KIDYBINSKI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH du Forez</name>
      <address>
        <city>Montbrison</city>
        <zip>42600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra VOISIN-GILLET</last_name>
      <email>douleur@ch-forez.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Päul CHAUSSINAND</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GHR MSA - CETD - Site Muller</name>
      <address>
        <city>Mulhouse</city>
        <zip>68070</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Lédée</last_name>
      <email>patledee132@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Patrick Lédée</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nord</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia JEGO</last_name>
      <email>Patricia.JEGO@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Julien NIZARD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHR Orléans</name>
      <address>
        <city>Orléans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Morin</last_name>
      <email>alexandra.morin@chr-orleans.fr</email>
    </contact>
    <investigator>
      <last_name>Blandine Armand</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Perpignan</name>
      <address>
        <city>Perpignan</city>
        <zip>66046</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin QUESADA</last_name>
      <email>kevin.quesada@ch-perpignan.fr</email>
    </contact>
    <investigator>
      <last_name>Gilles MOTTE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine Rannou</last_name>
      <email>delphine.RANNOU@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Delphine Rannou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH René Dubos</name>
      <address>
        <city>Pontoise</city>
        <zip>95300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine GOULVENT</last_name>
      <email>sandrine.goulvent@ght-novo.fr</email>
    </contact>
    <investigator>
      <last_name>Noella RODENBUCHER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Annecy Genevois</name>
      <address>
        <city>Pringy</city>
        <zip>74374</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine Bernard</last_name>
      <email>dbernard@ch-annecygenevois.fr</email>
    </contact>
    <investigator>
      <last_name>Stéphane Ferrando</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Saint-Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ouafa Namous</last_name>
      <email>ouafa.namous@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Christelle Creach</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pierre Paul Riquet - CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Cantagrel</last_name>
      <email>cantagrel.n@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Nathalie Cantagrel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Valence</name>
      <address>
        <city>Valence</city>
        <zip>26953</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaëlle Bayart Combeaux</last_name>
      <email>gcombeaux@ch-valence.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine Delorme</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Jacques Lacarin</name>
      <address>
        <city>Vichy</city>
        <zip>03200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dephine Roux</last_name>
      <email>Delphine.Roux@ch-vichy.fr</email>
    </contact>
    <investigator>
      <last_name>Mitra Najjar Ravan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord Ouest - Site Villefranche-sur-Saône</name>
      <address>
        <city>Villefranche-sur-Saône</city>
        <zip>69655</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Coline Perrier</last_name>
      <email>CPerrier@lhopitalnordouest.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle Bobineau</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Médipôle Hôpital Mutualiste</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laetitia Paradisi-Prieur</last_name>
      <email>l.paradisi-prieur@resamut.fr</email>
    </contact>
    <investigator>
      <last_name>Mario Barmaki</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

